SCHEMBL9515053

SCHEMBL9515053

CNn1cnc2c(=O)[nH]c(=O)[nH]c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GDA Q9Y2T3 2/20 0.41
▸ PNP P00491 1/20 0.39
▸ ALDH1A1 P00352 4/20 0.35
▸ MEN1 O00255 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ KDM4E B2RXH2 3/20 0.34
▸ BLM P54132 2/20 0.34
▸ TDP1 Q9NUW8 2/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ PABPC1 P11940 1/20 0.34
▸ ADORA2A P29274 1/20 0.34
▸ ADORA2B P29275 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ CASP7 P55210 1/20 0.34
▸ PMP22 Q01453 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ ACHE P22303 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28383481 0.78 PNP (0.38) GDAPNPALDH1A1KDM4EBLM
SCHEMBL4560085 0.77 GDA (0.53) GDAPNPALDH1A1MEN1KMT2A
SCHEMBL10998 0.77 GDA (0.53) GDAPNPALDH1A1MEN1KMT2A
SCHEMBL2562945 0.76 PNP (0.38) GDAPNPALDH1A1KDM4EBLM
SCHEMBL9669020 0.76 PNP (0.35) GDAPNPALDH1A1KDM4EBLM
SCHEMBL2352519 0.76 PNP (0.43) GDAPNPALDH1A1MEN1KMT2A
Ammonia Solution, Strong SCHEMBL28309009 0.75 GDA (0.51) GDAPNPALDH1A1MEN1KMT2A
SCHEMBL28079039 0.75 GDA (0.51) GDAPNPALDH1A1MEN1KMT2A
SCHEMBL27708662 0.75 GDA (0.51) GDAPNPALDH1A1MEN1KMT2A
SCHEMBL21539483 0.73 GDA (0.36) GDAPNPALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-5156033-A — — None — — JP disclosed
EP-3013340-B9 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF JANSSEN PHARMACEUTICALS INC (US) 2023-10-04 — — EP disclosed
EP-3013340-B1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF JANSSEN BIOPHARMA INC (US) 2023-06-07 — — EP disclosed
EP-3797782-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF FOR USE IN THE TREATMENT OF VIRAL INFECTIONS Janssen BioPharma, Inc. (US) 2021-03-31 — — EP disclosed
EP-2616513-B1 CATALYSTS AND METHODS FOR POLYMER SYNTHESIS SAUDI ARAMCO TECH CO (SA) 2019-11-06 — — EP disclosed
EP-3466959-A1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF Janssen BioPharma, Inc. (US) 2019-04-10 — — EP disclosed
EP-3424938-A1 4'-AZIDOALKYL-SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF Alios Biopharma, Inc. (US) 2019-01-09 — — EP disclosed
WO-2018144955-A1 CONSTRUCT-PEPTIDE COMPOSITIONS AND METHODS OF USE THEREOF SILVERBACK THERAPEUTICS, INC. (US) 2018-08-09 — — WO disclosed
EP-3013843-B1 SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF ALIOS BIOPHARMA INC (US) 2018-05-30 — — EP disclosed
JP-H05156033-A PR0DUCTION OF CROSSLINKED POLYOLEFIN MOLDING MITSUI TOATSU CHEM INC 1993-06-22 — — JP disclosed
Send feedback